default author photo

Frederick F. Lang

University of Texas at Houston - Department of Neurosurgery

1400 Holcombe Blvd

FC7.2000, Unit Number: 442

Houston, TX 77030

United States

SCHOLARLY PAPERS

3

DOWNLOADS

113

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Window-of-Opportunity Clinical Trial of Pembrolizumab in Recurrent Glioblastoma (GBM) Patients

Number of pages: 99 Posted: 14 Oct 2018
University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, Baylor University, College of Medicine, Department of Neurology, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuropathology, University of Texas at Houston - Department of Pathology, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Radiology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology and University of Texas at Houston - Department of Neurosurgery
Downloads 51 (1,052,702)

Abstract:

Loading...

glioblastoma, immune checkpoint inhibitor, clinical trial, PD-1

2.

Glial Cell Adhesion Molecule (GlialCAM) and Aquaporin-4 Coordinately Drive Glioblastoma Cell Invasion in the Brain

Number of pages: 57 Posted: 21 Mar 2023
University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Bioinformatics and Computational Biology, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Pathology, University of Texas at Houston - Department of Neurosurgery and University of Texas at Houston - Department of Neurosurgery
Downloads 35 (1,249,711)

Abstract:

Loading...

extracellular matrix, astrocyte, hepaCAM, angiogenesis, brain cancer, AQP4, megalencephalic leukoencephalopathy with subcortical cysts 1 (Mlc1)

3.

Recurrent ERBB2 Alterations are Associated with Esophageal Adenocarcinoma Brain Metastases

Number of pages: 22 Posted: 12 Mar 2025
University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Oxford, University of Texas at Houston - MD Anderson Cancer Center, Stanford University, University of Texas at Houston - MD Anderson Cancer Center, University of Pennsylvania, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Neurosurgery, University of Oxford, University of Texas at Houston - MD Anderson Cancer Center and University of Texas at Houston - MD Anderson Cancer Center
Downloads 27 (1,359,097)
Citation 1

Abstract:

Loading...

Esophageal adenocarcinoma, brain metastasis, ERBB2, JAK2, micronuclei, ecDNA, tumor microenvironment, T cell infiltration, ADC therapies, immunotherapy